Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients

Nephrol Dial Transplant. 1993;8(10):1115-7.

Abstract

Sera from 82 haemodialysis patients were tested for anti-HCV, HCV-RNA, and HBsAg. Alanine aminotransferase (ALT) activity was monitored weekly for 2 months. Anti-HCV was positive in 31 patients (37.8%), showing different single-peptide patterns. HCV-RNA was detected in 26 anti-HCV-positive patients (84%) and also in two of 21 anti-HCV-negative patients. Twenty-seven (87%) of the 31 anti-HCV-positive patients had persistently normal ALT values; 22 of these patients were HCV-RNA positive. The four patients with elevated ALT values had HCV viraemia. HBsAg was positive in nine anti-HCV-negative patients. The close correlation between HCV viraemia and HCV status, independently of ALT values, requires that anti-HCV dialysis patients must be considered potentially infective and dialysed with reserved machines and/or in separate shifts.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alanine Transaminase / metabolism
  • Female
  • Hepacivirus / genetics
  • Hepacivirus / immunology*
  • Hepatitis Antibodies / analysis*
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis B Surface Antigens / immunology
  • Hepatitis C / etiology*
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • RNA, Viral / analysis
  • Renal Dialysis / adverse effects*
  • Time Factors
  • Transfusion Reaction
  • Viremia / etiology*

Substances

  • Hepatitis Antibodies
  • Hepatitis B Surface Antigens
  • RNA, Viral
  • Alanine Transaminase